Dr. Klaff is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
800 SW 39th St
#110
Renton, WA 98057- Is this information wrong?
Summary
- Dr. Leslie Klaff is an endocrinologist and is a Medical Director of Rainier Clinical Research Center, an independent research center in Renton WA. He received his medical degree from University of the Witwatersrand in 1971 and was in Academic and private Endocrine practice until 2007 when he entered full time research. The
center specializes in pharmaceutical and device testing for diabetes and metabolic disorders.
Retired Feb 2022
Education & Training
University of Cape TownPhD, 1983
University of the WitwatersrandClass of 1971
Certifications & Licensure
WA State Medical License 1984 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Fellow (FACE) American Association of Clinical Endocrinology, 2003
- Fellow (FRCP) Edin Royal College of Physicians (Edinburgh), 1990
Publications & Presentations
PubMed
- 16 citationsGlucagon receptor antagonist volagidemab in type 1 diabetes: a 12-week, randomized, double-blind, phase 2 trial.Jeremy Pettus, Schafer C Boeder, Mark P Christiansen, Douglas S Denham, Timothy S Bailey, Halis K Akturk, Leslie J Klaff, Julio Rosenstock, Mickie H M Cheng, Bruce W B...> ;Nature Medicine. 2022 Oct 1
- 9 citationsDasiglucagon, a next-generation glucagon analogue, for treatment of severe hypoglycaemia via an autoinjector device: Results of a phase 3, randomized, double-blind trial.Timothy S. Bailey, Julie Willard, Leslie J. Klaff, Jenine Y Stone, Anita E. Melgaard, Ramin Tehranchi> ;Diabetes, Obesity & Metabolism. 2021 Oct 1
- 6 citationsLong-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D ExtensionJuliana M. Bue-Valleskey, Leslie J. Klaff, Jang Ik Cho, Mary Anne Dellva, Nanette C. Schloot, Janet Tobian, Junnosuke Miura, Dominik Dahl> ;Diabetes Therapy. 2021 Jan 17
- Join now to see all
Press Mentions
Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D ExtensionJanuary 17th, 2021
Professional Memberships
- Fellow
- Member
Hospital Affiliations
UW Medicine/University of Washington Medical CenterSeattle, Washington
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
